Early detection blood test for breast cancer being developed by Michell Cancer Institute

Breast Cancer News

Early detection blood test for breast cancer being developed by Michell Cancer Institute
Blood TestEarly DetectionMitchell Cancer Institute
  • 📰 mynbc15
  • ⏱ Reading Time:
  • 28 sec. here
  • 9 min. at publisher
  • 📊 Quality Score:
  • News: 38%
  • Publisher: 63%

Researchers at the USA Health Mitchell Cancer Institute are developing a blood test for an aggressive subtype of breast cancer.The test is for early detection a

Researchers at the USA Health Mitchell Cancer Institute are developing a blood test for an aggressive subtype of breast cancer .

"These cells are very aggressive. They do not progress through pre-cancer stages like the other breast cancer subtypes, and that is where they become very aggressive. The average survival rate is six to twelve months, and conventional chemotherapy is the only way to treat these patients,” said Mitchell Cancer Institute researcher Dr. Santanu Dasgupta.

Dasgupta says the goal is to create a mitochondrial DNA test to detect cancer in the localized stage. That is when there are no signs it has spread outside the breast.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

mynbc15 /  🏆 262. in US

Blood Test Early Detection Mitchell Cancer Institute Triple Negative Diagnose Researchers Treatment

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Become a Harvard Radcliffe Institute Fellow - Cambridge, Massachusetts job with Harvard Radcliffe InstituteBecome a Harvard Radcliffe Institute Fellow - Cambridge, Massachusetts job with Harvard Radcliffe InstituteApplications for the 2025-2026 Fellowship | Harvard Radcliffe Institute Harvard Radcliffe Institute fellows are exceptional scientists, writers, scholars, public intellectuals, and artists whose work is making a difference in their professional fields and in the wider world.
Read more »

FDA approves new blood test for colon cancer screening: ‘Early detection is critical’FDA approves new blood test for colon cancer screening: ‘Early detection is critical’The FDA has approved a new blood test for colorectal cancer. Shield, made by Guardant Health, is the first approved blood test that is considered a primary screening option for the disease.
Read more »

T-DM1 Yields 'Outstanding' Long-Term Outcomes in Early HER2+ Breast CancerT-DM1 Yields 'Outstanding' Long-Term Outcomes in Early HER2+ Breast CancerOne year of adjuvant T-DM1 demonstrated high 5-year invasive disease-free survival rates in patients with stage I HER2-positive breast cancer, researchers reported.
Read more »

5 Early Warning Signs of Cancer in Dogs5 Early Warning Signs of Cancer in DogsDon't dismiss these symptoms. Get your pet to the vet right away.
Read more »

Genetics and Lifestyle Choices Can Affect Early Prostate Cancer DeathsGenetics and Lifestyle Choices Can Affect Early Prostate Cancer DeathsMen at higher genetic risk for prostate cancer have a significantly higher risk for early death from prostate cancer and may benefit from lifestyle-focused prevention strategies.
Read more »

Risks, symptoms and treatments for lung cancer, the deadliest cancer in the worldRisks, symptoms and treatments for lung cancer, the deadliest cancer in the worldLung cancer is a potentially fatal disease. Learn about common risk factors, symptoms to watch out for, types of lung cancer and common treatment options.
Read more »



Render Time: 2025-04-06 23:58:18